Results 191 to 200 of about 4,076 (204)

Binding Characteristics of Brivaracetam, a Selective, High Affinity SV2A Ligand in Rat, Mouse and Human Brain: Relationship to Anti-Convulsant Properties

European Journal of Pharmacology, 2011
Karine Leclercq, Michel Gillard, Bruno Fuks   +2 more
exaly  

Differential Expression of SV2A in Hippocampal Glutamatergic and GABAergic Terminals During Postnatal Development

Brain Research, 2019
Gisela Gómez-Lira
exaly  

The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae*♦

Journal of Biological Chemistry, 2014
David A Pearce, Attila D Kovacs
exaly  

Mechanisms of Action of Levetiracetam and Newer SV2A Ligands

2009
HENRIK KLITGAARD, ALAIN MATAGNE
openaire   +1 more source

Levetiracetam-Induced a New Seizure Type in a Girl With a Novel SV2A Gene Mutation

Clinical Neurology and Neurosurgery, 2019
Liankun Ren, Di Wang, Yuping Wang
exaly  

SV2A Protein Is a Broad-Spectrum Anticonvulsant Target: Functional Correlation Between Protein Binding and Seizure Protection in Models of Both Partial and Generalized Epilepsy

Neuropharmacology, 2008
Rafal M Kaminski, Michel Gillard, Henrik Klitgaard   +2 more
exaly  

Preferential Increase in the Hippocampal Synaptic Vesicle Protein 2A (SV2A) by Pentylenetetrazole Kindling

Biochemical and Biophysical Research Communications, 2009
Yukihiro Ohno, Shizuka Ishihara, Masashi Sasa   +2 more
exaly  

Kindling-Associated SV2A Expression in Hilar GABAergic Interneurons of the Mouse Dentate Gyrus

Neuroscience Letters, 2012
Yukihiro Ohno, Shizuka Ishihara, Masashi Sasa   +2 more
exaly  

Modulation of the Conformational State of the SV2A Protein by an Allosteric Mechanism as Evidenced by Ligand Binding Assays

British Journal of Pharmacology, 2013
Rafal M Kaminski, Michel Gillard
exaly  

新たなてんかん治療標的分子synaptic Vesicle Protein 2A（SV2A）の機能解析

Folia Pharmacologica Japonica, 2018
Yukihiro Ohno, Saki Shimizu, Tadao Serikawa   +2 more
exaly